Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Exp Dermatol ; 46(2): 328-337, 2021 Mar.
Article in English | MEDLINE | ID: mdl-32939795

ABSTRACT

Immune checkpoint inhibitors (ICI) may cause eruptions resembling cutaneous autoimmune diseases. There are six cases of immunotherapy-associated subacute cutaneous lupus erythematosus (SCLE) in the literature. We present details of five patients referred to the Skin Toxicity Program at the Dana-Farber Cancer Institute/Brigham and Women's Cancer Center who developed de novo immunotherapy-associated SCLE-like eruptions, along with clinicopathological correlation and highlight potential mechanistic features and important diagnostic points. Two patients were maintained on topical corticosteroids, antihistamines and photoprotection. One had complete clearance and two had improvement with addition of hydroxychloroquine. Four patients continued their immunotherapy uninterrupted, while one had immunotherapy suspended for a month before restarting at full dose. Histopathologically, this series illustrates the temporal evolution of ICI-induced immune cutaneous reactions with SCLE subtype. Looking beyond the universally present lichenoid infiltrate, features of evolving SCLE were evident. We hypothesize that programmed death-1 blockade may induce immunological recognition of previously immunologically tolerated drug antigens, leading to epitope spreading and the SCLE phenotype.


Subject(s)
Exanthema/pathology , Immune Checkpoint Inhibitors/adverse effects , Lupus Erythematosus, Cutaneous/chemically induced , Lupus Erythematosus, Cutaneous/pathology , Neoplasm Metastasis/drug therapy , Administration, Topical , Adrenal Cortex Hormones/administration & dosage , Adrenal Cortex Hormones/therapeutic use , Aged , Antimalarials/administration & dosage , Antimalarials/therapeutic use , Combined Modality Therapy , Female , Histamine Antagonists/administration & dosage , Histamine Antagonists/therapeutic use , Humans , Hydroxychloroquine/administration & dosage , Hydroxychloroquine/therapeutic use , Immune Checkpoint Inhibitors/therapeutic use , Immunotherapy/adverse effects , Lupus Erythematosus, Cutaneous/diagnosis , Male , Middle Aged , Retrospective Studies , Sun Protection Factor , Treatment Outcome , Withholding Treatment
2.
Resuscitation ; 103: 1-6, 2016 06.
Article in English | MEDLINE | ID: mdl-26997477

ABSTRACT

AIM: Hydrogen sulphide (H2S) intoxication in man is frequently associated with a fatal outcome. In small animal models hydrogen sulphide has demonstrated profound protection against hypoxia. No reports that focus on a potential protective effect in humans have been published. METHODS: The frequency and outcome of a large cohort of hydrogen sulphide intoxications is described. RESULTS: From 1980 until 2013, 35 accidents totalling 56 victims occurred of whom at least 24 (43%) survived. Of the 8 patients with documented cardiopulmonary resuscitation on the scene, 6 (75%) survived. In some of these cases with good outcome the exposure time to very high hydrogen sulphide levels before extraction and resuscitation was more than 45min. CONCLUSION: Manure related hydrogen sulphide intoxication is associated with a high mortality, although in some cases, recovery appears to be far more favourable than the initial presentation would suggest. Possibly protection from hypoxic injury due to induction of a suspended animation-like state by hydrogen sulphide may be responsible.


Subject(s)
Hydrogen Sulfide/poisoning , Manure , Occupational Exposure/adverse effects , Out-of-Hospital Cardiac Arrest/mortality , Adult , Animals , Cardiopulmonary Resuscitation/mortality , Cardiopulmonary Resuscitation/statistics & numerical data , Child , Child, Preschool , Farmers , Female , Humans , Hypoxia/prevention & control , Male , Mice , Middle Aged , Netherlands/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...